A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Alcon and RxSight willjointly develop adjustable presbyopia-correcting intraocular lenses (PC-IOLs) under a new nonexclusive agreement, the companies announced July 6. The collaboration aims to com...
Harrow announced July 1 that it had relaunched Byooviz (ranibizumab-nuna), a Lucentis biosimilar, in the US. The Nashville, Tennessee, company secured US rights to Byooviz and another ophthalmic bi...
LensCrafters, part of French company EssilorLuxottica, announced June 30 that it was launching the first LensCrafters Vision & Eye Health Center, addingsurgical procedures and advanced diagnostics ...
Genentech announced June 30 that the US FDA had accepted its supplemental biologics license application (sBLA) for subcutaneous Enspryng (satralizumab) in thyroid eye disease (TED). The agency gran...
Twenty multinational ophthalmic specialists, including key opinion leaders, have developed a consensus-based classification system and questionnaire for reporting dysphotopsias after ophthalmic pro...
Bausch + Lomb reported July 9 the introduction of Orphia, a new AI-powered digital health platform intended to increase eye care providers’ efficiency. It will initially provide pre-surgery catarac...
Researchers in Singapore have developed a spinach-derived nanotechnology that enables corneal cells to produce a key antioxidant molecule when exposed to ambient light. The team at the National Uni...
Global nonprofit group HelpMeSee and its Indian subsidiary, HMS Vision Private Limited, have launched virtual training for manual small incision cataract surgery (MSICS) in Guwahati, India. Trainin...
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
A Multi-Step Approach for Accurate & Timely Data
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.